Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Insulin: The Receptor and Signaling Pathways

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...

Hormones Regulating Blood Glucose

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...

Glucagon-like Receptor Agonists

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...

Insulin Secretory Vesicles

Insulin Secretory Vesicles

Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...

Cell Specific Gene Expression

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

PNPLA3 I148M Variant Activates Hepatic Stellate Cells via AMIGO2 Upregulation Using iPSC-Derived Model.

Liver international : official journal of the International Association for the Study of the Liver·2026

Same author

A 3-step dorsal approach with the extracorporeal ventral traction method for laparoscopic hemihepatectomy.

Surgery today·2026

Same author

Validity of the Ajinomoto Group Nutrient Profiling System Against Two 24 h Urinary Excretions of Sodium, Potassium and Protein in Japanese Adults.

Nutrients·2026

Same author

Offset Conduction Velocity Reveals Prognostic Slowing of Motor Axons in Amyotrophic Lateral Sclerosis.

Muscle & nerve·2026

Same author

Cluster analysis of heart rate variability reveals subgroups with preserved and early-impaired autonomic regulation in amyotrophic lateral sclerosis.

BMC neurology·2026

Same author

Rehabilitation Management of Upper Limb Segmental Zoster Paresis Following Coronavirus 2019 Vaccination: A Case Report.

Progress in rehabilitation medicine·2026

Search research articles

Related Experiment Video

Updated: Jun 25, 2026

Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain

Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain

Published on: January 4, 2018

CXCL14 and insulin action.

Takahiko Hara¹, Yuki Nakayama

¹The Tokyo Metropolitan Institute of Medical Science, Tokyo Metropolitan Organization for Medical Research, Bunkyo-ku, Tokyo 113-8613, Japan.

Vitamins and Hormones

|March 3, 2009

Summary

Chemokine CXCL14 (C-X-C motif chemokine ligand 14) deficiency protects female mice from obesity and insulin resistance by reducing inflammation in white adipose tissue. CXCL14 regulates glucose metabolism and insulin signaling.

Area of Science:

Immunology
Metabolic research
Endocrinology

Background:

The physiological roles of CXCL14 (C-X-C motif chemokine ligand 14) are largely unknown.
CXCL14 exhibits chemoattractant activity for monocytes and dendritic precursor cells, suggesting a potential tumor suppressive function.
Previous studies indicated CXCL14 is dispensable for immune cell development in mice.

Purpose of the Study:

To investigate the physiological roles of CXCL14 in vivo, particularly concerning metabolism and inflammation.
To elucidate the function of CXCL14 in obesity-induced insulin resistance.

Main Methods:

Analysis of CXCL14-deficient (CXCL14(-/-)) mice fed a high-fat diet (HFD).
Assessment of metabolic parameters including body weight, glucose levels, insulin sensitivity, and adipose tissue macrophage infiltration.

More Related Videos

Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy

Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy

Published on: December 7, 2017

Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice

Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice

Published on: November 16, 2011

Related Experiment Videos

Last Updated: Jun 25, 2026

Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain

Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain

Published on: January 4, 2018

Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy

Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy

Published on: December 7, 2017

Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice

Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice

Published on: November 16, 2011

Investigation of CXCL14's effect on glucose uptake in cultured myocytes and insulin signaling pathways.

Main Results:

CXCL14(-/-) female mice are protected from obesity and associated metabolic dysfunction (hyperglycemia, hyperinsulinemia, insulin resistance) compared to wild-type mice.
CXCL14 expression is elevated in white adipose tissue (WAT) of obese mice.
CXCL14 promotes macrophage recruitment into WAT, contributing to chronic inflammation and insulin resistance; it also attenuates insulin-stimulated glucose uptake in myocytes.

Conclusions:

CXCL14 is a novel regulator of glucose metabolism and insulin resistance.
CXCL14 mediates its effects by influencing macrophage infiltration into WAT and interacting with insulin signaling in skeletal muscle.
Targeting CXCL14 may offer a therapeutic strategy for metabolic disorders like insulin resistance.